Akitomi Shirato

Saiseikai Matsuyama Hospital

Papers

1

Total Citations

4

H-Index

1

About

Dr. Akitomi Shirato is a leading urological oncologist whose research focuses on prostate cancer epidemiology and surgical outcomes, particularly within Japanese populations. His most impactful work leverages large-scale, multi-center retrospective data to illuminate real-world treatment patterns. Dr. Shirato is a key contributor to the Medical Investigation Cancer Network (MICAN) study, a landmark initiative that provides critical insights into cancer care across Ehime, Japan. His highly cited 2023 paper, "Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study," meticulously documents the evolving surgical landscape for prostate cancer over a decade. By analyzing trends in radical prostatectomy, his research offers essential benchmarks for surgical volume, patient demographics, and clinical decision-making. This work has garnered 4 citations, establishing a foundational reference for future studies on prostate cancer management in Japan. Dr. Shirato’s dedication to rigorous, population-based research continues to shape our understanding of urological cancer care and improve patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Saiseikai Matsuyama Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago